Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jennifer Diamond

Concepts (272)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Triple Negative Breast Neoplasms
11
2021
155
5.090
 Why?
Breast Neoplasms
17
2021
2006
3.430
 Why?
Pyrimidines
9
2021
414
2.800
 Why?
Antineoplastic Combined Chemotherapy Protocols
14
2022
1430
2.470
 Why?
Antineoplastic Agents
20
2020
2062
2.460
 Why?
Neoplasms
14
2022
2163
1.960
 Why?
Immunoconjugates
5
2021
87
1.960
 Why?
Receptor, ErbB-2
8
2021
333
1.920
 Why?
Paclitaxel
6
2022
209
1.880
 Why?
Pyrazoles
6
2021
405
1.610
 Why?
Camptothecin
7
2022
97
1.590
 Why?
Protein Kinase Inhibitors
9
2022
889
1.560
 Why?
Quinoxalines
2
2020
71
1.530
 Why?
Ovarian Neoplasms
4
2020
386
1.500
 Why?
Azepines
3
2020
80
1.470
 Why?
Piperazines
3
2020
330
1.470
 Why?
Antibodies, Monoclonal, Humanized
8
2021
667
1.350
 Why?
Neutropenia
4
2022
134
1.060
 Why?
Gene Expression Regulation, Neoplastic
5
2020
1216
0.920
 Why?
beta Catenin
2
2020
229
0.880
 Why?
Breast Neoplasms, Male
2
2018
31
0.870
 Why?
Xenograft Model Antitumor Assays
10
2021
786
0.850
 Why?
Cancer Care Facilities
1
2020
33
0.810
 Why?
Maximum Tolerated Dose
9
2022
190
0.810
 Why?
Benzoxazoles
1
2020
23
0.810
 Why?
Histone Deacetylase Inhibitors
1
2022
204
0.790
 Why?
Carcinoma, Lobular
2
2018
59
0.790
 Why?
Lymphocytes, Tumor-Infiltrating
1
2020
117
0.780
 Why?
eIF-2 Kinase
1
2019
30
0.770
 Why?
Cyclin-Dependent Kinase 4
1
2018
37
0.720
 Why?
Cyclin-Dependent Kinase 6
1
2018
37
0.710
 Why?
Wnt Signaling Pathway
1
2019
138
0.680
 Why?
Drug Resistance, Neoplasm
4
2020
707
0.670
 Why?
Aurora Kinase A
4
2020
58
0.660
 Why?
Female
41
2021
64422
0.660
 Why?
Carcinoma, Ductal, Breast
1
2018
94
0.660
 Why?
Tumor Microenvironment
1
2020
423
0.650
 Why?
Pyrazines
2
2018
81
0.640
 Why?
Colonic Neoplasms
1
2018
224
0.610
 Why?
Neoadjuvant Therapy
1
2018
311
0.590
 Why?
Humans
51
2022
119016
0.580
 Why?
Angiopoietin-1
1
2015
9
0.570
 Why?
Angiopoietin-2
1
2015
14
0.570
 Why?
Aged
20
2021
20607
0.530
 Why?
Tumor Suppressor Protein p53
3
2016
475
0.530
 Why?
Uterine Cervical Neoplasms
1
2017
213
0.520
 Why?
Middle Aged
23
2021
29243
0.490
 Why?
Cell Line, Tumor
8
2022
2933
0.480
 Why?
Tumor Suppressor Proteins
1
2015
286
0.480
 Why?
Proto-Oncogene Proteins c-met
1
2013
74
0.470
 Why?
Point Mutation
1
2013
239
0.450
 Why?
Cell Proliferation
8
2020
2382
0.450
 Why?
Adult
23
2022
32799
0.450
 Why?
Treatment Outcome
12
2022
9492
0.450
 Why?
Dose-Response Relationship, Drug
6
2022
2197
0.450
 Why?
Recombinant Fusion Proteins
1
2015
701
0.450
 Why?
Triazoles
1
2013
141
0.450
 Why?
Angiogenesis Inhibitors
3
2018
221
0.430
 Why?
Carcinoma, Renal Cell
1
2013
176
0.420
 Why?
Mitochondria
1
2017
834
0.410
 Why?
Neoplasm Recurrence, Local
4
2021
844
0.410
 Why?
Clinical Trials, Phase I as Topic
2
2020
55
0.410
 Why?
Colorectal Neoplasms
4
2022
636
0.410
 Why?
Trastuzumab
3
2021
106
0.410
 Why?
Genes, BRCA2
1
2009
24
0.390
 Why?
Genes, BRCA1
1
2009
29
0.390
 Why?
Neoplasm Metastasis
4
2020
617
0.390
 Why?
Nuclear Proteins
1
2015
640
0.390
 Why?
Biomarkers, Tumor
2
2014
1080
0.380
 Why?
BRCA2 Protein
1
2009
43
0.370
 Why?
Mice, Nude
5
2020
704
0.370
 Why?
Pregnancy Complications, Neoplastic
1
2009
53
0.370
 Why?
Molecular Targeted Therapy
3
2019
382
0.360
 Why?
Aged, 80 and over
8
2020
6913
0.360
 Why?
Kidney Neoplasms
1
2013
336
0.360
 Why?
Chemotherapy, Adjuvant
2
2021
336
0.360
 Why?
Neoplasm Staging
5
2021
1248
0.360
 Why?
Thrombophilia
1
2009
76
0.360
 Why?
Quinolines
2
2021
141
0.350
 Why?
Aromatase Inhibitors
2
2018
54
0.350
 Why?
Receptors, Progesterone
2
2021
339
0.330
 Why?
DNA-Binding Proteins
1
2015
1432
0.320
 Why?
Antibodies, Monoclonal
3
2020
1325
0.320
 Why?
Receptors, Estrogen
2
2021
403
0.310
 Why?
Mice
9
2021
15850
0.310
 Why?
Antineoplastic Agents, Immunological
2
2019
163
0.310
 Why?
Apoptosis
6
2022
2639
0.300
 Why?
Models, Biological
1
2014
1814
0.290
 Why?
Liver Neoplasms
1
2009
467
0.280
 Why?
Cyclophosphamide
2
2018
237
0.260
 Why?
Lung Neoplasms
1
2017
2246
0.250
 Why?
Radiosurgery
2
2019
320
0.240
 Why?
Doxorubicin
2
2018
316
0.240
 Why?
Cyclin-Dependent Kinase 9
1
2022
10
0.230
 Why?
Histone Deacetylase 1
1
2022
19
0.230
 Why?
Histones
2
2022
548
0.230
 Why?
Biopsy
2
2018
1076
0.230
 Why?
Fluorouracil
1
2022
154
0.230
 Why?
Aurora Kinases
2
2012
34
0.230
 Why?
G2 Phase Cell Cycle Checkpoints
3
2022
40
0.230
 Why?
Disease Progression
4
2019
2524
0.220
 Why?
Topoisomerase I Inhibitors
2
2022
16
0.220
 Why?
Anthracyclines
1
2021
34
0.220
 Why?
Administration, Oral
3
2022
808
0.220
 Why?
Animals
10
2021
35392
0.220
 Why?
Taxoids
1
2021
94
0.220
 Why?
Acetylation
1
2022
227
0.210
 Why?
Biliary Tract Neoplasms
1
2021
21
0.210
 Why?
Androstadienes
1
2021
105
0.210
 Why?
Carboplatin
1
2021
143
0.200
 Why?
Diarrhea
2
2019
181
0.200
 Why?
Heterografts
1
2021
131
0.200
 Why?
Necrosis
2
2019
231
0.200
 Why?
Male
14
2021
61786
0.200
 Why?
Hospitals, University
1
2021
195
0.200
 Why?
Fatigue
2
2022
313
0.200
 Why?
Drug Administration Schedule
3
2017
813
0.200
 Why?
Histone Deacetylases
1
2022
210
0.200
 Why?
Mechanistic Target of Rapamycin Complex 2
1
2020
55
0.200
 Why?
Benzodiazepines
1
2021
116
0.200
 Why?
Myeloid Cell Leukemia Sequence 1 Protein
1
2019
25
0.190
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2020
102
0.190
 Why?
Medicare
2
2021
698
0.190
 Why?
Immune System
1
2021
202
0.190
 Why?
Kaplan-Meier Estimate
1
2021
904
0.180
 Why?
Albumins
1
2019
101
0.180
 Why?
Aquaporin 4
1
2019
72
0.180
 Why?
Maintenance Chemotherapy
1
2018
25
0.180
 Why?
Antibodies, Bispecific
1
2018
29
0.180
 Why?
Tumor Cells, Cultured
1
2020
1008
0.180
 Why?
Nausea
1
2018
116
0.170
 Why?
Aminopyridines
1
2018
91
0.170
 Why?
Vascular Endothelial Growth Factor A
2
2018
531
0.170
 Why?
Mastectomy
1
2018
117
0.170
 Why?
Breast
1
2018
151
0.170
 Why?
Benzimidazoles
1
2018
146
0.160
 Why?
Topotecan
1
2017
13
0.160
 Why?
Mice, Inbred BALB C
1
2020
1328
0.160
 Why?
Purines
1
2018
167
0.160
 Why?
Drug Therapy, Combination
1
2020
1018
0.160
 Why?
Radiotherapy, Adjuvant
1
2018
196
0.160
 Why?
Isoflavones
1
2017
26
0.160
 Why?
Calcium-Binding Proteins
1
2018
222
0.160
 Why?
Carbolines
1
2017
34
0.160
 Why?
Heterocyclic Compounds, 4 or More Rings
1
2017
15
0.160
 Why?
Disease Models, Animal
2
2021
3894
0.160
 Why?
Imidazoles
1
2018
264
0.160
 Why?
Inhibitory Concentration 50
2
2016
83
0.160
 Why?
Immunotherapy
1
2021
478
0.160
 Why?
Nanoparticles
1
2021
336
0.160
 Why?
Survival Analysis
1
2020
1420
0.150
 Why?
Insulin-Like Growth Factor I
1
2018
293
0.150
 Why?
Neoplasms, Radiation-Induced
1
2016
76
0.150
 Why?
Neoplasms, Second Primary
1
2016
75
0.150
 Why?
GPI-Linked Proteins
1
2016
56
0.150
 Why?
Hypertension
2
2018
1220
0.150
 Why?
Cell Survival
1
2019
1137
0.150
 Why?
Retrospective Studies
3
2021
12249
0.140
 Why?
Adaptor Proteins, Signal Transducing
1
2018
392
0.140
 Why?
Tumor Protein p73
1
2015
17
0.140
 Why?
Antibodies, Neoplasm
1
2015
32
0.140
 Why?
Hodgkin Disease
1
2016
117
0.140
 Why?
Risk Reduction Behavior
1
2016
221
0.140
 Why?
Phosphorylation
1
2019
1754
0.130
 Why?
Maytansine
1
2014
14
0.130
 Why?
Pyridines
1
2018
501
0.130
 Why?
Demography
1
2015
292
0.130
 Why?
Brain Edema
1
2014
66
0.130
 Why?
Randomized Controlled Trials as Topic
1
2019
1222
0.130
 Why?
Drug Interactions
1
2015
401
0.130
 Why?
Survival Rate
2
2019
1874
0.120
 Why?
Threonine
1
2013
52
0.120
 Why?
Protein Kinases
1
2015
336
0.120
 Why?
Sulfones
1
2014
105
0.120
 Why?
Analgesics, Opioid
1
2021
780
0.120
 Why?
Glycine
1
2014
167
0.120
 Why?
Tumor Stem Cell Assay
1
2012
39
0.120
 Why?
Drug Evaluation, Preclinical
1
2013
198
0.120
 Why?
Methionine
1
2013
158
0.120
 Why?
Heterozygote
1
2013
257
0.120
 Why?
Drug Design
1
2013
172
0.120
 Why?
Computational Biology
1
2015
489
0.110
 Why?
Treatment Failure
1
2013
343
0.110
 Why?
Disease-Free Survival
1
2014
692
0.110
 Why?
In Situ Hybridization, Fluorescence
1
2013
343
0.110
 Why?
Time Factors
2
2020
7099
0.110
 Why?
Cellular Senescence
1
2012
147
0.110
 Why?
Neovascularization, Pathologic
1
2013
296
0.110
 Why?
Carcinoma in Situ
1
2011
47
0.110
 Why?
Cluster Analysis
1
2012
472
0.110
 Why?
Cell Transformation, Neoplastic
1
2013
339
0.100
 Why?
Vascular Endothelial Growth Factor Receptor-2
1
2010
88
0.100
 Why?
Risk Assessment
1
2020
3250
0.100
 Why?
Brain Neoplasms
2
2019
1000
0.100
 Why?
Receptor Protein-Tyrosine Kinases
1
2013
282
0.100
 Why?
Mutation
2
2012
3468
0.100
 Why?
United States
3
2021
12886
0.100
 Why?
Colorado
1
2020
4577
0.100
 Why?
Sequence Analysis, DNA
1
2013
741
0.100
 Why?
Tumor Burden
1
2010
289
0.100
 Why?
Pregnancy Trimester, Second
1
2009
81
0.090
 Why?
Mastectomy, Segmental
1
2009
91
0.090
 Why?
Keratinocytes
1
2010
244
0.090
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2009
64
0.090
 Why?
Pregnancy Trimester, First
1
2009
124
0.090
 Why?
Clinical Trials as Topic
2
2013
1022
0.090
 Why?
Lymph Node Excision
1
2009
156
0.090
 Why?
Apoptosis Regulatory Proteins
1
2009
215
0.090
 Why?
Infusions, Intravenous
2
2019
407
0.080
 Why?
Cell Adhesion Molecules
2
2019
188
0.080
 Why?
Antigens, Neoplasm
2
2019
232
0.080
 Why?
Risk Factors
1
2020
9266
0.080
 Why?
Risk
1
2009
956
0.080
 Why?
Prognosis
2
2018
3592
0.080
 Why?
Gene Expression Profiling
1
2012
1590
0.070
 Why?
Cell Cycle
2
2018
594
0.070
 Why?
Combined Modality Therapy
2
2019
1230
0.060
 Why?
Mesylates
1
2022
6
0.060
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2022
63
0.060
 Why?
Signal Transduction
2
2014
4919
0.060
 Why?
Chimerism
1
2021
29
0.050
 Why?
Lymphoid Tissue
1
2021
65
0.050
 Why?
Lymphocyte Subsets
1
2021
84
0.050
 Why?
Liver
1
2009
1873
0.050
 Why?
Mice, SCID
1
2021
372
0.050
 Why?
SEER Program
1
2021
208
0.050
 Why?
Mice, Inbred NOD
1
2021
597
0.050
 Why?
M Phase Cell Cycle Checkpoints
1
2018
23
0.050
 Why?
Infant, Newborn
1
2009
5203
0.040
 Why?
Tissue Distribution
1
2018
366
0.040
 Why?
Anemia
1
2019
168
0.040
 Why?
Pregnancy
1
2009
5546
0.040
 Why?
Retreatment
1
2016
70
0.040
 Why?
Cetuximab
1
2016
98
0.040
 Why?
Platinum
1
2016
38
0.040
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2016
122
0.040
 Why?
Neoplasm Transplantation
1
2016
263
0.040
 Why?
Drug Screening Assays, Antitumor
1
2016
193
0.040
 Why?
Hematopoietic Stem Cell Transplantation
1
2021
572
0.040
 Why?
Proto-Oncogene Proteins p21(ras)
1
2016
238
0.040
 Why?
History, Ancient
1
2015
45
0.040
 Why?
Databases, Genetic
1
2015
173
0.030
 Why?
Biomarkers
2
2016
3583
0.030
 Why?
Opioid-Related Disorders
1
2021
360
0.030
 Why?
DNA Damage
1
2017
373
0.030
 Why?
Mice, Knockout
1
2021
2862
0.030
 Why?
Phenotype
1
2021
2938
0.030
 Why?
Drug Combinations
1
2013
309
0.030
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2015
233
0.030
 Why?
Intracellular Signaling Peptides and Proteins
1
2015
407
0.030
 Why?
Immunohistochemistry
1
2016
1802
0.030
 Why?
Biopsy, Needle
1
2011
201
0.030
 Why?
Cohort Studies
1
2021
5129
0.030
 Why?
HT29 Cells
1
2010
38
0.030
 Why?
Transcription, Genetic
1
2017
1472
0.020
 Why?
Ki-67 Antigen
1
2010
110
0.020
 Why?
Cell Cycle Proteins
1
2014
573
0.020
 Why?
ErbB Receptors
1
2013
575
0.020
 Why?
Enzyme Inhibitors
1
2014
941
0.020
 Why?
Capillary Permeability
1
2010
163
0.020
 Why?
Protein-Tyrosine Kinases
1
2013
456
0.020
 Why?
Proto-Oncogene Proteins
1
2014
726
0.020
 Why?
Patient Selection
1
2013
710
0.020
 Why?
Patient Satisfaction
1
2013
621
0.020
 Why?
Follow-Up Studies
1
2018
5000
0.020
 Why?
Membrane Proteins
1
2015
1110
0.020
 Why?
Positron-Emission Tomography
1
2010
309
0.020
 Why?
Algorithms
1
2015
1552
0.020
 Why?
Magnetic Resonance Imaging
1
2019
3266
0.020
 Why?
Tomography, X-Ray Computed
1
2016
2431
0.020
 Why?
Brain
1
2014
2787
0.010
 Why?
Young Adult
1
2014
11181
0.010
 Why?
Diamond's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (272) concept(s)
_
Co-Authors Expand Description
See all (60) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2023 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)